
Sponsored
Pharma leaders on embracing nonlinear careers, leading inclusively, and preserving a distinct voice as AI-generated content becomes the norm.

Dr. Nicholas Botwood is a prominent leader and R&D visionary who has more than 25 years of experience translating scientific discoveries into novel oncology medicines and industry-leading franchises. As Head of R&D and Chief Medical Officer at Syndax Pharmaceuticals, he led the team to secure a second FDA-approved indication for Revuforj (revumenib), making it the first-ever targeted therapy approved for relapsed/refractory NPM1-mutated AML, an aggressive blood cancer associated with poor outcomes. He also spearheaded the launch of a global Phase 3 trial which incorporates a novel surrogate endpoint that could meaningfully shorten the time required to bring this promising new therapy to newly diagnosed patients with NPM1-mutated AML.

Sponsored
Pharma leaders on embracing nonlinear careers, leading inclusively, and preserving a distinct voice as AI-generated content becomes the norm.

Sponsored
Pharma leaders on building networks, asking for stretch opportunities, and approaching AI and remote work with curiosity and confidence.

Sponsored
Pharma leaders on why AI safety must be designed in from the start—and why human oversight is non-negotiable when patients are affected.

Sponsored
Pharma leaders on building cultures where high performance and human connection coexist—and how shared mission drives progress in complex disease.

Sponsored
Pharma leaders on why shared purpose and authentic human connection remain the foundation of effective leadership as digital tools advance.

Sponsored
Pharma leaders on redesigning workflows for agility—and how AI is compressing timelines and reshaping roles across tech, marketing, and MLR.

Sponsored
Pharma leaders on balancing discipline and flexibility—and staying consistent in strengths and values as business contexts constantly shift.

Sponsored
Pharma leaders on building trust in AI through transparency and validation—and helping teams adapt as analytics roles evolve with the technology.

Sponsored
Pharma leaders on navigating agentic AI without a playbook—and keeping patient and physician benefit as the north star through uncertainty.

Sponsored
Pharma leaders on building global strategy from a product’s universal truth—then adapting locally and adjusting plans as new data emerges.

Sponsored
Pharma leaders on sitting with uncertainty before acting—and tailoring communication to resonate with investors and scientific audiences alike.

Sponsored
Pharma leaders on building teams with rigor and trust—and retaining talent by connecting individual growth to mission and patient impact.

Sponsored
Pharma leaders share how trust, mission alignment, and guiding teams through rapid change—including AI—drive results for patients.